Clinical Trials
임상시험 트래커
국내사는 전체 임상 이력, 글로벌 메이저는 진행 중 파이프라인을 추적합니다. ClinicalTrials.gov API v2에서 6시간 주기로 수집합니다.
기업
60 results (top 60)
- 2상모집 중· Moderate to Severe Psoriatic Arthritis중등도에서 중증 건선성관절염 환자에서 DDY391의 효능, 안전성 및 내약성 평가
A Study to Assess the Efficacy, Safety and Tolerability of DDY391 in Participants With Moderate to Severe Psoriatic Arthritis
리드: 노바티스
- 2상모집 중· Cutaneous Lichen Planus중등도 또는 중증 피부 편평태선 환자에서 GIA632의 다양한 용량에 대한 유효성 및 안전성을 평가하는 연구
A Study to Assess the Efficacy and Safety of GIA632 Across a Range of Doses in Participants With Moderate to Severe Cutaneous Lichen Planus
리드: 노바티스
- 2상모집 중· Sjögren's Disease쇼그렌 증후군 환자에 대한 DDY391의 효능, 안전성 및 내약성 평가 2a/b 상 연구
A Phase 2a/b Study to Assess the Efficacy, Safety and Tolerability of DDY391 in Participants With Sjögren's Disease
리드: 노바티스
- 2상모집 중· High-Risk Localized Prostate CancerPSMA-High: EBRT/PSMA617/ADT vs. EBRT/ADT
PSMA-High: EBRT/ PSMA617/ ADT vs. EBRT/ ADT
협력: 노바티스
- 2상모집 중· Primary Immune Thrombocytopenia (ITP)원발성 면역혈소판감소증(ITP) 환자에서 이아날루맙과 트롬보포이에틴 수용체 작용제의 내약성 평가 연구
A Study to Assess the Tolerability of Ianalumab (VAY736) With Investigator's Choice Thrombopoietin Receptor Agonist (IC TPO-RA) in Patients With Primary Immune Thrombocytopenia (ITP)
리드: 노바티스
- 2상모집 중· Papulopustular Rosacea성인 구진농포 장미증 환자에서 레미브루티닙(LOU064)의 효능, 안전성 및 내약성을 조사하는 2상 연구
A Phase 2 Study to Investigate the Efficacy, Safety and Tolerability of Remibrutinib (LOU064) in Adult Patients With Papulopustular Rosacea (PPR)
리드: 노바티스
- 2상모집 중· Anatomic Stage IV Breast Cancer AJCC v84기 또는 재발성 유방암 치료를 위한 177Lu-DOTATATE
177Lu-DOTATATE for the Treatment of Stage IV or Recurrent Breast Cancer
협력: 노바티스
- 2상모집 중· Primary Immune Thrombocytopenia이전에 이날루마브로 이득을 본 1차 면역성 혈소판 감소증(ITP) 및 따뜻한 항체 자가면역용혈성빈혈(wAIHA) 성인 환자 대상 이날루마브 연구
Study of Ianalumab in Adults With Primary Immune Thrombocytopenia (ITP) and Warm-antibody Autoimmune Hemolytic Anemia (wAIHA) Who Have Previously Benefited From Ianalumab
리드: 노바티스
- 2상모집 중· Liver Cancer전이성 간세포암종에서 68Ga-PSMA-11 PET 기반 방사성리간드 치료
68Ga-PSMA-11 PET-directed Radioligand Therapy in Metastatic Hepatocellular Carcinoma (HCC)
협력: 노바티스
- 2상모집 중· Hypercholesterolaemia고혈압 및 동반 고콜레스테롤혈증 환자에서 QCZ484와 인클리시란 조합의 약력학 평가
A Study to Evaluate the Pharmacodynamics of a Combination of QCZ484 and Inclisiran in Participants With Hypertension and Concomitant Hypercholesterolemia
리드: 노바티스
- 2상모집 중· Hypertension (HTN)고혈압 환자에서 QCZ484의 공개 추가 안전성 및 효과 연구
An Open-label Extension Safety and Efficacy Study of QCZ484 in Hypertensive Patients.
리드: 노바티스
- 2상모집 중· Chronic Myelogenous Leukemia소아 Ph+ CML-CP에서의 아스시미닙 효능 및 안전성 평가
Study to Determine the Efficacy and Safety of Asciminib in Pediatric Patients With Ph+ CML-CP
리드: 노바티스
- 2상모집 중· Immunoglobulin A Nephropathy (IgAN)IgA 신병증에서 지가키바트의 효과 평가
A Study to Assess the Effects of Zigakibart on IgA Nephropathy.
리드: 노바티스
- 2상모집 중· Non-segmental VitiligoA Phase IIb Dose-ranging Study to Assess the Efficacy and Safety of GIA632 in Participants With Non-segmental Vitiligo
리드: 노바티스
- 2상모집 중· Geographic Atrophy Secondary to Age-related Macular DegenerationA Study to Investigate Efficacy and Safety of FWY003 Compared With Placebo in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration
리드: 노바티스
- 2상모집 중· Uncomplicated Plasmodium Falciparum MalariaPlatform Study to Evaluate the Efficacy and Safety of Anti-malarial Agents in Participants With Uncomplicated Plasmodium Falciparum Malaria (Cohort C2)
리드: 노바티스
- 2상모집 중· Oligometastatic Prostate AdenocarcinomaAlpha-Emitting Radionuclide or Beta-Emitting Radionuclide With Metastasis-Directed Stereotactic Body Radiotherapy for the Treatment of Recurrent, Oligometastatic Prostate Adenocarcinoma
협력: 노바티스
- 2상모집 중· CryptosporidiosisStudy Testing the Efficacy, Safety, and Tolerability of EDI048 in Cryptosporidium Infection Model in Healthy Adults
리드: 노바티스
- 2상모집 중· PIK3CA-related Overgrowth Spectrum (PROS)EPIK-P4: A Phase II Single-arm Study to Assess the Efficacy, Safety and Pharmacokinetics of Alpelisib (BYL719) in Pediatric and Adult Patients With PIK3CA-related Overgrowth Spectrum (PROS)
리드: 노바티스
- 2상모집 중· Alzheimer's DiseaseA Clinical Trial to Learn About the Effects of VHB937 in People With Early Alzheimer's Disease
리드: 노바티스
- 2상모집 중· HER2 Negative Breast CancerImpact of Omitting Chemo Based on Patient's Selection for ER-Positive, HER2-Negative Breast Cancer With Ribociclib and Endocrine Therapy
협력: 노바티스
- 2상모집 중· Chronic Urticaria (CU): Chronic Inducible Urticaria (CINDU) and Chronic Spontaneous Urticaria (CSU)Study of Remibrutinib (LOU064) Efficacy and Safety and Exploration of Its Mechanism of Action in Participants With Chronic Urticaria
리드: 노바티스
- 2상모집 중· Metastatic Castration-Resistant Prostate CarcinomaLow PSMA SUV Boost (LPS-Boost): Intensified 177Lu-PSMA-617 Treatment for Patients With Metastatic Castrate-Resistant Prostate Cancer With Low PSMA Expressing Disease
협력: 노바티스
- 2상모집 중· Chagas DiseaseA Study of Efficacy, Safety, Tolerability of LXE408 in Participants With Chronic Chagas Disease.
리드: 노바티스
- 2상모집 중· Prostate AdenocarcinomaNeoadjuvant Lu-177-PSMA-617 in Patients With High Risk Localized Prostate Cancer Undergoing Radical Prostatectomy
협력: 노바티스
- 2상모집 중· Glomerulonephritis, IGAStudy to Evaluate the Impact of Iptacopan on Top of SOC on Biopsy Changes in Kidneys of Adult Patients With IgAN
리드: 노바티스
- 2상모집 중· Chronic Myeloid Leukemia (CML)Open-label Study of Asciminib for CML-CP or CML-AP Patients With T315I Mutation Who Are Resistant, Intolerant or Ineligible to Ponatinib.
리드: 노바티스
- 2상모집 중· Malignant Solid TumorsPhase II Study of Asciminib for Second-line Treatment of Chronic Phase Chronic Myeloid Leukemia
협력: 노바티스
- 2상모집 중· Diffuse Cutaneous Systemic SclerosisA Clinical Study to Evaluate Ianalumab in Participants With Diffuse Cutaneous Systemic Sclerosis
리드: 노바티스
- 2상모집 중· Castration-Resistant Prostate CarcinomaVorinostat and 177Lu-PSMA-617 for the Treatment of PSMA-Low Metastatic Castration-Resistant Prostate Cancer
협력: 노바티스
- 2상모집 중· High Grade GliomaStudy of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant
협력: 노바티스
- 2상모집 중· Castration-Resistant Prostate CarcinomaRe-treatment With 177Lu-PSMA-617 for the Treatment of Metastatic Castration-Resistant Prostate Cancer, RE-LuPSMA Trial
협력: 노바티스
- 2상모집 중· Neuroendocrine Tumors177Lu-DOTATATE Modified Delivery Based on Individualized Dosimetry
협력: 노바티스
- 2상모집 중· Chronic Myeloid LeukemiaPhase II Study Assessing Efficacy and Safety of Asciminib in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase.
협력: 노바티스
- 2상모집 중· Uncomplicated Plasmodium Falciparum MalariaPlatform Study to Evaluate the Efficacy and Safety of Anti-malarial Agents in Patients With Uncomplicated Plasmodium Falciparum Malaria
리드: 노바티스
- 2상모집 중· CraniopharyngiomaTreatment of BRAF ( B-Rapidly Accelerated Fibrosarcoma) Mutated Papillary Craniopharyngioma
협력: 노바티스
- 2상모집 중· HER2-negative Breast CancerAlpelisib/iNOS Inhibitor/Nab-paclitaxel in Patients With HER2 Negative Metaplastic Breast Cancer (MpBC)
협력: 노바티스
- 2상모집 중· Anaplastic Thyroid CancerNEO- and Adjuvant Targeted Therapy in Braf-mutated Anaplastic Cancer of the Thyroid (NEO-ATACT Study)
협력: 노바티스
- 2상모집 중· Megalencephaly-capillary Malformation Polymicrogyria Syndrome (MCAP)Assessment of the Efficacy and Safety of Alpelisib (BYL719) in Pediatric and Adult Patients With Megalencephaly-CApillary Malformation Polymicrogyria Syndrome (MCAP)
협력: 노바티스
- 2상모집 중· Lupus NephritisStudy of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V
리드: 노바티스
- 2상모집 중· Squamous Cell Anal CarcinomaCombination of Spartalizumab, mDCF and Radiotherapy in Patients With Metastatic Squamous Cell Anal Carcinoma
협력: 노바티스
- 2상모집 중· Neuroblastoma Recurrent177Lutetium-DOTATATE in Children With Primary Refractory or Relapsed High-risk Neuroblastoma
협력: 노바티스
- 2상모집 중· CancerThe Drug Rediscovery Protocol (DRUP Trial)
협력: 암젠, 아스트라제네카, BMS, GSK, 일라이 릴리, 머크(MSD), 노바티스, 화이자
- 2상모집 중· Lymphoma, Non-HodgkinTAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
협력: 아스트라제네카, BMS, 일라이 릴리, 노바티스, 화이자, 로슈
BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.